Skip to main content

Hologic Value Stock - Dividend - Research Selection

Hologic

ISIN: US4364401012 , WKN: 879100

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. It offers Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and related products, and accessories comprising digital and film-based mammography systems; computer-aided detection for mammography; minimally invasive breast biopsy devices; breast biopsy site markers; and breast biopsy guidance systems. In addition, it offers Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D, a software product that provides 2D images; Selenia digital mammography platform; and SecurView Workstation. Further, it provides SculpSure, MonaLisa Touch, Vectus diode, and Cellulaze laser devices; PicoSure and Icon aesthetic systems; MedLite, RevLite, Cynergy, Elite, and SmartLipo products; and system components. Additionally, it offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient\'s extremities, such as the hand, wrist, knee, foot, and ankle. The company sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Hologic Goes Private In $18 Billion Blackstone, TPG Acquisition

2026-04-08
Blackstone and TPG complete their acquisition of Hologic for up to $79 per share. Hologic transitions to a private company. Read more.

Hologic hires former Baxter leader José Almeida as CEO

2026-04-08
The company appointed Almeida as chief executive in conjunction with the completion of an $18.3 billion go-private deal.

ImpediMed Appoints Erik Anderson as Chief Executive Officer

2026-04-07
ImpediMed, a leader in the development and commercialization of medical technologies to clinically monitor and manage fluid and body composition, and its Board of Directors have announced the appointment of Erik Anderson as Managing Director and Chief Executive Officer. Anderson, who joined the company's Board of Directors in February 2026, succeeds Dr. Parmjot Bains. His appointment is effective April 7, 2026.

Casey's General Stores Stock Has Been On a Tear. Now It's Joining The S&P 500

2026-04-07
Casey's General Stores is set to join the S&P 500 on Thursday, replacing Hologic after the medtech firm was acquired by Blackstone and TPG.

Top Midday Stories: Stocks Fall as US-Iran Ceasefire Hopes Fade; Health Insurance Stocks Rise After Big Medicare Advantage Payment Rate Bump

2026-04-07
All three major US stock indexes were down in late-morning trading Tuesday, as President Donald Trum

Blackstone and TPG Complete Acquisition of Hologic

2026-04-07
MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas, April 07, 2026--Blackstone and TPG Complete Acquisition of Hologic Accomplished MedTech leader Joe Almeida named Chief Executive Officer

A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack

2026-04-07
Looking back on medical devices & supplies - imaging, diagnostics stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Hologic (NASDAQ:HOLX) and its peers.

Stocks making the biggest moves midday: Apple, Arm Holdings, Broadcom, UnitedHealth & more

2026-04-07
Here are the stocks posting the biggest moves in midday trading.

Casey's General Stores To Join S&P 500; DigitalOcean, Broadstone Net Lease Move Up In Index Reshuffle

2026-04-07
Casey's General Stores (CASY) will replace Hologic (HOLX) in the S&P 500 effective before the openin

Stocks making the biggest moves premarket: Broadcom, UnitedHealth, Casey's General Stores and more

2026-04-07
These are the stocks posting the largest moves in early trading.